This information was published on 2025-12-01T12:51:35 for IP Right Acceptance Published.
| Field | Value |
| (210) | 2605344 (IR 1887100) |
| (220) |
16 Oct 2025
|
| (300) |
KR, 18 Apr 2025, 4020250065979
|
| (500) |
The applicant has advised that the words in the Mark have no meaning in English
|
| (511) (510) |
Class 5
Monoclonal antibodies for medical purposes; pharmaceutical preparations for the treatment of arthritis; pharmaceutical preparations for the treatment of spondylitis; pharmaceutical preparations for the treatment of psoriasis; immunomodulatory pharmaceutical preparations; pharmaceutical preparations for the treatment of autoimmune diseases. |
| (540) | KIZEFMA |
| (550) | Word |
| (730) |
CELLTRION, INC.
|
Find out more about publications on the About page.